FIELD: medicine.
SUBSTANCE: to predict the malignant tumour disease recurrence, severity of the skin immune delayed-type hypersensitivity reaction is determined during cancer patients treatment and rehabilitation. Tumour-associated antigens are injected intradermally, followed by skin hyperemia zone size measurement in millimeters, after a predetermined time after TAA administration. Absence of skin flushing or skin flushing size of less than the reference value indicates a high risk of cancer recurrence. Skin redness flushing size over the reference value indicates a low risk of cancer recurrence.
EFFECT: invention allows to assess the state of the immune system anti-tumour activity, does not require application of specialized laboratory equipment and specially trained personnel.
2 cl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF RECURRENCES OF POSTOPERATIVE MENINGIOMAS | 2018 |
|
RU2689795C1 |
| METHOD FOR APPLYING VACCINE THERAPY FOR TREATING ONCOLOGIC DISEASES | 2000 |
|
RU2192883C2 |
| IMMUNOTHERAPY METHOD FOR TREATING PATIENTS FOR SOLID TUMORS BY APPLYING TUMOR LYSATE WITH BETALEUKINE ADJUVANT | 2004 |
|
RU2267326C2 |
| METHOD FOR PREDICTION OF DEVELOPING METASTASES IN UTERINE CANCER PATIENTS BASED ON ANALYSIS OF MAGEA1, MAGEB2 AND PRAME1 GENE EXPRESSION | 2018 |
|
RU2698895C1 |
| METHOD OF RECURRENT ENDOMETRIAL CANCER PREDICTION BASED ON PTEN AND CYP1B1 GENES EXPRESSION LEVEL | 2015 |
|
RU2605302C1 |
| DIFFERENTIAL DIAGNOSIS METHOD FOR DETERMINING NEOPLASTIC FORMATIONS IN LUNG | 1992 |
|
RU2051385C1 |
| METHOD FOR DETECTING EFFICIENCY OF ANTI-TUMOR THERAPY OF SKIN MELANOMAS | 2004 |
|
RU2280483C2 |
| RECURRENT AND METASTASING CERVICAL CARCINOMA TREATMENT EFFECTIVENESS PREDICTION METHOD | 2007 |
|
RU2353928C1 |
| METHOD FOR PREDICTION OF RECURRENT CARCINOMA OF VULVA | 2013 |
|
RU2532342C1 |
| METHOD FOR PREDICTING THE COURSE OF THE DISEASE IN PATIENTS WITH LOCAL RENAL CELL CARCINOMA OF THE KIDNEY | 2018 |
|
RU2674677C1 |
